In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Direct-to-Consumer Advertising

Executive Summary

Drug company spending on direct-to-consumer advertising is soaring and could reach $10 billion, or as much as 30% of all promotional spending, by 2005, if current trends continue. But some powerful groups, most notably, doctors, pharmacists and managed care organizations, have begun to express their concern, worried that such advertising inappropriately influences patient prescribing.
Advertisement

Related Content

Big Pharma Continues to Rely on Marketing to Consumers
For Devices, an Elusive Consumer Appeal

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV000840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel